Product Details:
Payment & Shipping Terms:
|
Molecular Weight: | 9.1kD | Formulation: | RhIGF-1LR3 Is Lyophilized With Mannitol As The Stabilizer |
---|---|---|---|
Purity: | Greater Than 90% | Usage: | Cell Culture, Stem Cell Culture, Vaccine Research |
Production Type: | Recombinant Protein | ED50: | ≤1ng/ml |
High Light: | Oryza Sativa IGF 1 Long R3,Recombinant IGF 1 Long R3,Recombinant LR3 IGF-1 |
IGF 1 Long R3 Recombinant Growth Factors Oryza Sativa Origin Lyophilized With Saline
Description
As an expression platform with rice endosperm cell as the carrier, it has a great advantage compared with the bacteria bioreactor. Firstly, rice is a self – pollination crop, greatly guarantee the genetic stability; Secondly, there is almost sterile condition in the endosperm cells, which is easy to purify it and avoid some bacteria themselves impurities. Thereby, Healthgen Biotech rhIGF-1 LR3 has less endotoxin level, which is less than 5.0 EU/mg. It is very useful for the cell culture, research use and nutrition care.
Healthegn Biotech’s quality control system has been certified by ISO 9001: 2015 and ensures standardized process as well as qualified products. Healthgen Biotech facility is compliant with GMP.
Quick Details
Product Name | Recombinant Insulin-Like Growth Factor 1, LR3 |
Source | Yeast |
Catalog No. | HYC007M01 |
Physical Appearance | White lyophilized powder |
Formulation | rhIGF-1 LR3 is lyophilized with saline. |
Purity | >90% |
Endotoxin | Less than 5.0 EU/mg |
Restrictions | FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY. NOT INTENDED FOR DIRECT USE ON HUMANS. |
Advantages
1. Healthgen Biotech rhIGF-1 LR3 is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.
2. Healthgen Biotech rhIGF-1 LR3 has excellent batch consistency. Using self-pollination rice as the bioreactor to express the LR3 IGF-1 with the world's advanced facility and top production proceeding to extract and purify the rhIGF-1 LR3, Healthgen can ensure the excellent consistency of rhIGF-1 LR3 from different batches.
3. Healthgen Biotech has a professional quality control department, in which 50% of them have master's degree or higher. There are 14 employees in the quality department, 9 of them are in QA and 5 are in QA. All of them have rich experience in analysis research or quality inspection. Half of them have graduated diploma. Every year there are more than 50 training courses, which cover GMP, SOP, specification, hygiene, QA, QC issues, etc.
Supplemental Description
Healthgen Biotech has strong technical force and advanced and complete protein expression and purification technology development and large-scale production facilities. Self-developed rice endosperm cell expression platform (OryzHiExp), which is domestic initiative and the international leader, has such advantages: high expression level, safety, scale-up easily, simple production process and environmental protection etc. After 10 years of unremitting efforts, Healthgen Biotech has established recombinant protein expression and purification technology platform to customize recombinant protein or peptide expression and purification process service for pharmaceuticals, health products, scientific research and industrial reagents. Using the OryzHiExp platform, Healthgen Biotech has achievements in developing and commercializing a series of medium ingredients, including recombinant human serum albumin (OsrHSA), recombinant α-1 antitrypsin (OsrhAAT), recombinant human lactoferrin (OsrhLF), recombinant human basic fibroblast growth factor (OsrhbFGF), recombinant human insulin-like growth factor-1 LR3 (rhIGF-1 LR3), recombinant human epidermal growth factor(rhEGF) and recombinant human fibronectin(OsrhFN), which can provide a full set of solutions for animal component free cell culture medium.
Contact Person: cjing
Tel: +8615071115810